/ /

Cornea

Cyclosporine for dry eye associated with anti-PD-1 therapy
Cyclosporine for dry eye associated with anti-PD-1 therapyTopical cyclosporine may be useful for treating dry eyes associated with immunomodulatory agents like nivolumab, which markedly upregulate T cell activation. In caring for patients with ocular side effects associated with cancer treatment, the delivery of proper ophthalmic care is critical.
16 most popular stories of 2016
16 most popular stories of 2016Here is your roundup of what made top news in 2016!
2016 Resident Writer's Award Winner: 10 tips for TENA 59-year-old otherwise healthy man presented with an acute-onset diffuse rash involving over 90% of his body surface area, including oral, genital, and ocular mucosal involvement. Initial ophthalmic examination was notable for development of extensive corneal epithelial defects in both eyes as well as conjunctival sloughing and pseudomembrane formation.
Top ophthalmic challenges in 2017In this Q&A with members of the Ophthalmology Times Europe Editorial Advisory Board, participants take a look at some of the top challenges and opportunities facing ophthalmologists in Europe today.
Crosslinking showing potential for refractive correction
Crosslinking showing potential for refractive correctionPhotorefractive intrastromal cross-linking is being developed for non-invasive correction of low refractive errors.
Advances in femto provide better results, fewer complicationsAdvances in femtosecond laser assisted cataract surgery (FLACS) providing better results, fewer complications, and higher rates of patient satisfaction.
Bowman layer transplantation effective in advanced keratoconus
Bowman layer transplantation effective in advanced keratoconusIsolated Bowman layer transplantation can reduce and stabilize corneal ectasia in eyes with progressive advanced keratoconus, researchers said. “It flattens the cornea into a more normal position,” said Jack Parker, MD, a researcher at the Netherlands Institute for Innovative Ocular Surgery (NIIOS) in Rotterdam, The Netherlands. “It doesn’t give them perfect vision, but it keeps them from getting worse. It lets them to continue wearing their contact lenses.”
Achieving physiologic restoration in dry eyeTear osmolarity testing provides clinicians the opportunity to detect disease and select treatments to restore ocular surface health.
Re-bubbling cases show a higher endothelial cell loss post-DMEKAnalyses of data from 293 eyes undergoing uncomplicated Descemet membrane endothelial keratoplasty (DMEK) show that endothelial cell loss is greater in eyes that undergo a single re-bubbling for graft separation. The study, however, does not establish a causal association.
New dry eye treatment demonstrates rapid onset symptomatic reliefResults from the Phase 3 OPUS-3 trial provide evidence confirming a benefit of lifitegrast ophthalmic solution 5.0% (Xiidra, Shire) for significantly improving dry eye disease-related symptoms, as measured by Eye Dryness Score.